The Peptide Doctrine
Menu

Providers

What Is a Peptide Clinic? What to Expect at Your First Visit

A peptide clinic is a medical practice, hormone clinic or med spa where a licensed clinician prescribes peptides. What should happen at your first visit, step by step: history, exam, labs, the prescription, the pharmacy, injection teaching, follow-up and cost.

Published October 17, 2026 · 6 min read

Key takeaways

  • A peptide clinic is any practice where a licensed clinician prescribes peptide drugs: a medical office, a hormone or longevity clinic, a med spa with a prescriber, or a telehealth service. There is no peptide license or specialty.
  • A good first visit looks for reasons not to prescribe: a full history and medication list, an exam, baseline labs where the drug calls for them, and a follow-up date with a result that would make you stop.
  • You should leave knowing the dose in milligrams or micrograms, the vial concentration, the syringe units, and the name of the pharmacy that makes the drug. If the clinic hands you a vial from its own stock, it should come from an FDA-registered outsourcing facility.
  • Expect $150 to $500 for a first visit at a local clinic, plus $100 to $400 for labs. No clinic, however good the visit, can legally supply BPC-157, TB-500, CJC-1295 or ipamorelin.

A peptide clinic is a medical practice where a licensed clinician evaluates you and prescribes peptide drugs, such as GLP-1 medicines, sermorelin or PT-141, filled by a licensed pharmacy. It can be a doctor's office, a hormone or anti-aging clinic, a med spa with a prescriber, or a telehealth service; the label on the door does not matter, the clinician, the evaluation and the pharmacy do. Your first visit should take a full history, check your vitals, order labs, and end with a written dose, a named pharmacy and a follow-up date. Whether to go local or online is covered in our parent guide, peptide therapy near me versus online; how to check a clinic before you book is in how to vet a peptide therapy clinic.

What a peptide clinic is, and what it is not

There is no "peptide clinic" category in law. Any clinician with prescribing authority in your state can prescribe a peptide drug: a physician, or a nurse practitioner or physician assistant within the state's scope rules. A telehealth clinician must be licensed in the state where you are during the visit, because telehealth is treated as taking place at the patient's location (CCHP).

What a clinic can prescribe is set by federal law, not by the clinic. In October 2026 a pharmacy may supply the GLP-1 drugs (brand, or compounded only for a documented individual need), sermorelin, bremelanotide (PT-141), glutathione, NAD+ and topical GHK-Cu; the legal tracker has the status of each. Tesamorelin is the exception that trips clinics up: Egrifta's label lists a biologics license, BLA022505 (Egrifta label), and FDA says biological products deemed licensed on March 23, 2020 are not eligible for compounding (FDA notice, 2020), so the only lawful version is brand Egrifta.

Your first visit, step by step

What should happen, in order, and what each step tells you about the clinic:

StepWhat should happenWhat it tells you
1. IntakeForms on your history, every medication and supplement, your goal; some clinics order labs before the visitA clinic that wants labs first is planning to use them
2. Who you seeA named MD, DO, NP or PA licensed in your stateA "wellness consultant" or coach cannot prescribe
3. HistoryQuestions that look for reasons to say no: cancer, a personal or family history of medullary thyroid cancer or MEN 2 before a GLP-1, blood pressure and heart disease before PT-141, diabetes and pituitary history before sermorelin, pregnancy plansA visit that skips these is a sales call
4. Goal and evidenceWhich compound has evidence for your goal, what it will not do, and the alternatives, including no peptidePromises of pounds, years or "reversed aging" are a red flag
5. ExamBlood pressure, heart rate, weight, a look at injection sitesThe main reason to go in person
6. LabsBaseline tests matched to the drug, and a date to repeat themA plan with no recheck date is a subscription
7. PrescriptionCompound, dose in milligrams or micrograms, vial concentration, syringe units, frequency; brand by default for GLP-1 drugsIf the dose is only in "units", ask for the milligrams
8. PharmacyA named 503A pharmacy licensed in your state, or office stock from a 503B outsourcing facility"Our pharmacy partner" without a name is not an answer
9. Injection lessonYou draw up and give the first dose under supervisionThe step most often skipped, and the one that prevents errors
10. Follow-upA date, what result means continue or stop, and who to call about a side effectMonitoring is what separates treatment from a refill plan
11. CostThe total for three months, including labs, visits and dose changesA first-month price alone hides the real cost

Labs before the first dose and after

Labs follow the drug. Before a GLP-1, clinicians commonly check A1c or fasting glucose and kidney function; before sermorelin, IGF-1 and glucose, since a low IGF-1 is the main objective reason to prescribe and a high one is a reason not to. If a clinic also offers testosterone, the Endocrine Society guideline diagnoses low testosterone only with symptoms plus fasting morning total testosterone measured twice, and advises against treatment with, among other things, prostate or breast cancer or a raised hematocrit (Bhasin 2018). For NAD+ and glutathione no lab predicts a response, so skipping labs is defensible there and nowhere else. The full labs-by-goal table is in the complete guide to peptide therapy, and who qualifies for peptide therapy lists the contraindications by compound.

The prescription, the pharmacy and the injection lesson

Compounded drugs are not FDA-approved, and FDA does not check their quality before they are sold, so the pharmacy that makes yours is part of the treatment (FDA Q&A). Most clinics send the prescription to a pharmacy that fills it with your name on the label. Some dispense from their own refrigerator. Under FDA's guidance, compounding at a 503A pharmacy requires a prescription for an identified patient, and clinics obtain stock that is not patient-specific from outsourcing facilities registered under section 503B, which follow manufacturing standards and are inspected by FDA (FDA guidance, 2016). Either way, ask for the name; the vetting guide shows how to look it up.

Then insist on the injection lesson. In a poison-center series of three people harmed by compounded semaglutide from compounding pharmacies and an aesthetic spa, two injected ten times the intended dose; one had received a vial and syringes with no counseling, and one dosed in milliliters and units instead of milligrams (Lambson 2023). Before you leave, convert your dose with our peptide calculator or the units guide and have the clinician confirm the number. Technique is covered in how to inject peptides.

What the first visit costs

From our October 2026 cost guide: a first visit at a local clinic or med spa costs $150 to $500, sometimes credited toward a package, against $0 to $200 for telehealth. Baseline labs add $100 to $400. Medication dispensed in the office is often marked up two to four times the pharmacy price. All in, a local clinic typically costs $400 to $900 in the first month and $250 to $600 a month after. Compounded peptides are cash-pay; prescribed drugs and the visits usually qualify for HSA and FSA money.

Bottom line

A peptide clinic is only as good as three things you can check: a clinician licensed where you are, an evaluation that looks for reasons to say no, and a named pharmacy that makes a legal product. A good first visit ends with a dose in milligrams, a lab plan, a pharmacy name, a follow-up date and an injection you have already given once under supervision. If yours ends with a vial of BPC-157 and a price list, you were at a store, not a clinic.

Frequently asked questions

+What is a peptide clinic?

A peptide clinic is any practice where a licensed clinician prescribes peptide drugs: a primary-care or specialist office, a hormone or longevity clinic, a med spa with a prescriber, or a telehealth service. There is no special peptide license. What makes one legitimate is a clinician licensed in your state, an evaluation that looks for reasons not to prescribe, labs where the drug calls for them, and a named licensed pharmacy.

+Can I get peptides from a clinic?

Yes, if the peptide is one a pharmacy may legally supply. In October 2026 that means the GLP-1 drugs (brand, or compounded only for a documented individual need), sermorelin, bremelanotide (PT-141), glutathione, NAD+ and brand-only tesamorelin (Egrifta). No clinic can legally supply BPC-157, TB-500, CJC-1295 or ipamorelin, because no licensed pharmacy may compound them.

+Who is a good candidate for peptide therapy?

Someone with a goal that a legally available peptide has evidence for, no contraindication, and labs that support the choice: for example, an adult with obesity and no personal or family history of medullary thyroid cancer for a GLP-1 drug, or a premenopausal woman with low sexual desire and controlled blood pressure for bremelanotide. Our qualification guide lists the criteria by compound.

+What does a peptide treatment do?

It depends entirely on the peptide. GLP-1 drugs reduce appetite and produced average weight losses of 15 to 21% over 68 to 72 weeks in their trials. Sermorelin raises the body's own growth hormone and IGF-1. Bremelanotide treats low sexual desire in premenopausal women. NAD+ and glutathione have little controlled evidence. 'Peptide therapy' is a category, not a treatment.

+How much do peptide treatments cost?

At a local clinic, expect $150 to $500 for the first visit, $100 to $400 for baseline labs, and $400 to $900 in total for the first month, then $250 to $600 a month. Telehealth programs run about $200 to $500 in the first month and $150 to $450 after. Compounded peptides are cash-pay.

+Why would a doctor prescribe you peptides?

Because a peptide drug treats a condition you have and the evidence supports it: semaglutide or tirzepatide for obesity or type 2 diabetes, bremelanotide for hypoactive sexual desire disorder, tesamorelin (brand Egrifta) for HIV-associated abdominal fat. Off-label prescriptions such as sermorelin for low IGF-1 are legal when the drug can be legally supplied, but the evidence is thinner.

+Is peptide therapy the same as Botox?

No. Botox is botulinum toxin, an FDA-approved biologic and a large protein rather than a short peptide, injected into muscles by a clinician in the office for wrinkles and some medical conditions. Peptide therapy usually means a prescription peptide you inject at home on a schedule. Many med spas offer both, which is why the two get confused.

Sources

  1. SourceCenter for Connected Health Policy. Cross-state licensing: professional requirements (telehealth is considered rendered at the physical location of the patient). Read October 10, 2026. (2026)
  2. RegulatoryFDA. Compounding and the FDA: questions and answers (compounded drugs are not FDA-approved; oversight of pharmacies and outsourcing facilities). Content current as of September 16, 2025; read October 10, 2026. (2025)
  3. RegulatoryFDA. Prescription requirement under section 503A of the Federal Food, Drug, and Cosmetic Act: guidance for industry (section III.D, compounding office stock), December 2016. Read October 10, 2026. (2016)
  4. RegulatoryFDA. Notice to compounders: changes that affect compounding as of March 23, 2020 (biological products deemed licensed are not eligible for the 503A and 503B exemptions). Read October 10, 2026. (2020)
  5. LabelEgrifta WR (tesamorelin for injection) prescribing information, application BLA022505; DailyMed SPL published August 3, 2026, read October 10, 2026. (2026)
  6. GuidelineBhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2018;103:1715-44. (2018)
  7. StudyLambson JE, Flegal SC, Johnson AR. Administration errors of compounded semaglutide reported to a poison control center: case series. J Am Pharm Assoc 2023;63:1643-5. (2023)
T

Written by

The Peptide Doctrine Editorial Team

Our editors write from primary sources — peer-reviewed studies, FDA documents and pharmacy records — and grade every claim by the strength of its evidence. See our editorial policy for how articles are researched, reviewed and updated.

Disclosure. The Peptide Doctrine is an independent editorial project. It currently has no sponsor and runs no advertising: we accept no payment for reviews, rankings or placements, we run no affiliate links, and we do not sell or link to "research-use" peptide vendors. Content is educational and is not medical advice.

Related

Providers

Peptide Therapy Near Me vs Online: Costs, Oversight, Which Is Safer

Peptides near me or online? How a local peptide clinic and a telehealth program differ in October 2026: what each costs, who oversees the clinician and the pharmacy, which peptides either can legally supply, what the safety evidence shows and how to check one before you pay.

Updated Oct 17, 2026 · 12 min read

Providers

How to Vet a Peptide Therapy Clinic: 9 Questions to Ask

How to vet peptide therapy clinics, local or online: nine questions to ask before you pay, what a good answer sounds like, and how to verify each one yourself with free tools, from state license lookups to FDA's outsourcing-facility list and warning-letter search.

Updated Oct 17, 2026 · 6 min read

Providers

Who Qualifies for Peptide Therapy? Labs, Conditions, Contraindications

Who qualifies for peptide therapy depends on the drug, not the program: the labeled populations, baseline labs and contraindications for semaglutide, tirzepatide, tesamorelin, sermorelin, PT-141, NAD+ and glutathione, what rules people out across the board, and what a clinician should ask.

Updated Oct 12, 2026 · 7 min read